LPS-induced up-regulation of TGF-β receptor 1 is associated with TNF-α expression in human monocyte-derived macrophages

Journal of Leukocyte Biology

Volumn 83, Issue 5, 2008, Pages 1165-1173

  Chen, Yan ^a   Kam, Christy S K ^a   Feng, Qin Liu ^a   Liu, Yan ^a   Lui, Vincent C H ^a   Lamb, Jonathan R ^b   Tam, Paul K H ^a,c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

ALK5; Inflammation; Septic shock

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; ENZYME INHIBITION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INHIBITION KINETICS; MACROPHAGE; MALE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPTIC SHOCK; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CYTOKINES; DNA PRIMERS; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MONOCYTES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 46949085159     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0807521     Document Type: Article

References (38)

1. Cohen, J. (2002) The immunopathogenesis of sepsis. Nature 420, 885-891.
2. Parrillo, J. E. (1993) Pathogenetic mechanisms of septic shock. N. Engl. J. Med. 328, 1471-1477.
3. Michie, H. R., Spriggs, D. R., Manogue, K. R., Sherman, M. L., Revhaug, A., O'Dwyer, S. T., Arthur, K., Dinarello, C. A., Cerami, A., Wolff, S. M., et al. (1988) Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery 104, 280-286.
4. Pennica, D., Nedwin, G. E., Hayflick, J. S., Seeburg, P. H., Derynck, R., Palladino, M. A., Kohr, W. J., Aggarwal, B. B., Goeddel, D. V. (1984) Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 312, 724-729.
5. Imaizumi, T., Itaya, H., Fujita, K., Kudoh, D., Kudoh, S., Mori, K., Fujimoto, K., Matsumiya, T., Yoshida, H., Satoh, K. (2000) Expression of tumor necrosis factor-α in cultured human endothelial cells stimulated with lipopolysaccharide or interleukin-1α. Arterioscler. Thromb. Vasc. Biol. 20, 410-415.
6. Kermarrec, N., Selloum, S., Plantefeve, G., Chosidow, D., Paoletti, X., Lopez, A., Mantz, J., Desmonts, J. M., Gougerot-Pocidalo, M. A., Chollet-Martin, S. (2005) Regulation of peritoneal and systemic neutrophil-derived tumor necrosis factor-α release in patients with severe peritonitis: role of tumor necrosis factor-α converting enzyme cleavage. Crit. Care Med. 33, 1359-1364.
7. Arcaroli, J., Yum, H. K., Kupfner, J., Park, J. S., Yang, K. Y., Abraham, E. (2001) Role of p38 MAP kinase in the development of acute lung injury. Clin. Immunol. 101, 211-219.
8. Van den Blink, B., Juffermans, N. P., ten Hove, T., Schultz, M. J., van Deventer, S. J., van der Poll, T., Peppelenbosch, M. P. (2001) p38 mitogen-activated protein kinase inhibition increases cytokine release by macrophages in vitro and during infection in vivo. J. Immunol. 166, 582-587.
9. Blobe, G. C., Schiemann, W. P., Lodish, H. F. (2000) Role of transforming growth factor β in human disease. N. Engl. J. Med. 342, 1350-1358.
10. Goumans, M. J., Valdimarsdottir, G., Itoh, S., Rosendahl, A., Sideras, P., ten Dijke, P. (2002) Balancing the activation state of the endothelium via two distinct TGF-β type I receptors. EMBO J. 21, 1743-1753.
11. Goumans, M. J., Valdimarsdottir, G., Itoh, S., Lebrin, F., Larsson, J., Mummery, C., Karlsson, S., ten Dijke, P. (2003) Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFβ/ALK5 signaling. Mol. Cell 12, 817-828.
12. Marie, J. C., Letterio, J. J., Gavin, M., Rudensky, A. Y. (2005) TGF-β1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J. Exp. Med. 201, 1061-1067.
13. Monteleone, G., Kumberova, A., Croft, N. M., McKenzie, C., Steer, H. W., MacDonald, T. T. (2001) Blocking Smad7 restores TGF-β1 signaling in chronic inflammatory bowel disease. J. Clin. Invest. 108, 601-609.
14. Yingling, J. M., Blanchard, K. L., Sawyer, J. S. (2004) Development of TGF-β signaling inhibitors for cancer therapy. Nat. Rev. Drug Discov. 3, 1011-1022.
15. Inman, G. J., Nicolas, F. J., Callahan, J. F., Harling, J. D., Gaster, L. M., Reith, A. D., Laping, N. J., Hill, C. S. (2002) SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol. Pharmacol. 62, 65-74.
16. Liu, R. Y., Fan, C., Liu, G., Olashaw, N. E., Zuckerman, K. S. (2000) Activation of p38 mitogen-activated protein kinase is required for tumor necrosis factor-α-supported proliferation of leukemia and lymphoma cell lines. J. Biol. Chem. 275, 21086-21093.
17. Goebeler, M., Kilian, K., Gillitzer, R., Kunz, M., Yoshimura, T., Brocker, E. B., Rapp, U. R., Ludwig, S. (1999) The MKK6/p38 stress kinase cascade is critical for tumor necrosis factor-α-induced expression of monocyte-chemoattractant protein-1 in endothelial cells. Blood 93, 857-865.
18. Stellato, C., Beck, L. A., Gorgone, G. A., Proud, D., Schall, T. J., Ono, S. J., Lichtenstein, L. M., Schleimer, R. P. (1995) Expression of the chemokine RANTES by a human bronchial epithelial cell line. Modulation by cytokines and glucocorticoids. J. Immunol. 155, 410-418.
19. Vodovotz, Y., Kopp, J. B., Takeguchi, H., Shrivastav, S., Coffin, D., Lucia, M. S., Mitchell, J. B., Webber, R., Letterio, J., Wink, D., Roberts, A. B. (1998) Increased mortality, blunted production of nitric oxide, and increased production of TNF-α in endotoxemic TGF-β1 transgenic mice. J. Leukoc. Biol. 63, 31-39.
20. Perrella, M. A., Hsieh, C. M., Lee, W. S., Shieh, S., Tsai, J. C., Patterson, C., Lowenstein, C. J., Long, N. C., Haber, E., Shore, S., Lee, M. E. (1996) Arrest of endotoxin-induced hypotension by transforming growth factor β1. Proc. Natl. Acad. Sci. USA 93, 2054-2059.
21. Bultinck, J., Sips, P., Vakaet, L., Brouckaert, P., Cauwels, A. (2006) Systemic NO production during (septic) shock depends on parenchymal and not on hematopoietic cells: in vivo iNOS expression pattern in (septic) shock. FASEB J. 20, 2363-2365.
22. VanOtteren, G. M., Strieter, R. M., Kunkel, S. L., Paine III, R., Greenberger, M. J., Danforth, J. M., Burdick, M. D., Standiford, T. J. (1995) Compartmentalized expression of RANTES in a murine model of endotoxemia. J. Immunol. 154, 1900-1908.
23. Fox-Dewhurst, R., Alberts, M. K., Kajikawa, O., Caldwell, E., Johnson II, M. C., Skerrett, S. J., Goodman, R. B., Ruzinski, J. T., Wong, V. A., Chi, E. Y., Martin, T. R. (1997) Pulmonary and systemic inflammatory responses in rabbits with gram-negative pneumonia. Am. J. Respir. Crit. Care Med. 155, 2030-2040.
24. Waage, A., Halstensen, A., Espevik, T. (1987) Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1, 355-357.
25. Tracey, K. J., Beutler, B., Lowry, S. F., Merryweather, J., Wolpe, S., Milsark, I. W., Hariri, R. J., Fahey III, T. J., Zentella, A., Albert, J. D., et al. (1986) Shock and tissue injury induced by recombinant human cachectin. Science 234, 470-474.
26. Badger, A. M., Bradbeer, J. N., Votta, B., Lee, J. C., Adams, J. L., Griswold, D. E. (1996) Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J. Pharmacol. Exp. Ther. 279, 1453-1461.
27. Wadsworth, S. A., Cavender, D. E., Beers, S. A., Lalan, P., Schafer, P. H., Malloy, E. A., Wu, W., Fahmy, B., Olini, G. C., Davis, J. E., Pellegrino-Gensey, J. L., Wachter, M. P., Siekierka, J. J. (1999) RWJ 67657, a potent, orally active inhibitor of p38 mitogen-activated protein kinase. J. Pharmacol. Exp. Ther. 291, 680-687.
28. Fijen, J. W., Zijlstra, J. G., De Boer, P., Spanjersberg, R., Tervaert, J. W., Van Der Werf, T. S., Ligtenberg, J. J., Tulleken, J. E. (2001) Suppression of the clinical and cytokine response to endotoxin by RWJ-67657, a p38 mitogen-activated protein-kinase inhibitor, in healthy human volunteers. Clin. Exp. Immunol. 124, 16-20.
29. Ashcroft, G. S. (1999) Bidirectional regulation of macrophage function by TGF-β. Microbes Infect. 1, 1275-1282.
30. Garcia-Lazaro, J. F., Thieringer, F., Luth, S., Czochra, P., Meyer, E., Renteria, I. B., Galle, P. R., Lohse, A. W., Herkel, J., Kanzler, S. (2005) Hepatic over-expression of TGF-β1 promotes LPS-induced inflammatory cytokine secretion by liver cells and endotoxemic shock. Immunol. Lett. 101, 217-222.
31. Letterio, J. J., Roberts, A. B. (1996) Transforming growth factor-β1-deficient mice: identification of isoform-specific activities in vivo. J. Leukoc. Biol. 59, 769-774.
32. McCartney-Francis, N., Jin, W., Wahl, S. M. (2004) Aberrant Toll receptor expression and endotoxin hypersensitivity in mice lacking a functional TGF-β 1 signaling pathway. J. Immunol. 172, 3814-3821.
33. Kanamaru, Y., Sumiyoshi, K., Ushio, H., Ogawa, H., Okumura, K., Nakao, A. (2005) Smad3 deficiency in mast cells provides efficient host protection against acute septic peritonitis. J. Immunol. 174, 4193-4197.
34. Fargeas, C., Wu, C. Y., Nakajima, T., Cox, D., Nutman, T., Delespesse, G. (1992) Differential effect of transforming growth factor β on the synthesis of Th1- and Th2-like lymphokines by human T lymphocytes. Eur. J. Immunol. 22, 2173-2176.
35. Bogdan, C., Nathan, C. (1993) Modulation of macrophage function by transforming growth factor β, interleukin-4, and interleukin-10. Ann. N. Y. Acad. Sci. 685, 713-739.
36. Anderson, P. (2000) Post-transcriptional regulation of tumor necrosis factor α production. Ann. Rheum. Dis. 59 (Suppl. 1), i3-i5.
37. Annane, D., Bellissant, E., Cavaillon, J. M. (2005) Septic shock. Lancet 365, 63-78.
38. Vervloet, M. G., Thijs, L. G., Hack, C. E. (1998) Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock. Semin. Thromb. Hemost. 24, 33-44.